1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GENMAB - ADR
Genmab - ADR XNAS: GMAB
Strong Performer, Getting Expensive
Download real time
33.88 0.78 (2.36%)
Near 52W High of $35.43
1.9M
XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Genmab (ADR) is on 05 Feb 2026 for the purpose of Genmab AS Annual Report for 2025 See details

Genmab (ADR) - GMAB - stock price prediction, stock price target, analyst ratings from 8 analysts

Genmab (ADR) has a share price target of US$ 38, revenue growth forecast of 25.0%, and profit growth estimate of 8.4% for FY25, based on top 8 analyst calls.

Forecaster Screeners